| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3978242 | Brachytherapy | 2006 | 8 Pages |
Abstract
Patients with stenotic esophageal tumors that cannot be bypassed or who previously underwent chemotherapy are poor candidates for single-dose brachytherapy. For these patients, a higher and/or fractionated dose of brachytherapy or alternative palliative treatment modalities should be considered.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Marjolein Y.V. Homs, Ewout W. Steyerberg, Wilhelmina M.H. Eijkenboom, Peter D. Siersema, for the Dutch SIREC study group for the Dutch SIREC study group,